InvestorsObserver
×
News Home

Is PepGen Inc (PEPG) Stock at the Top of the Biotechnology Industry?

Wednesday, March 13, 2024 09:57 AM | InvestorsObserver Analysts

Mentioned in this article

Is PepGen Inc (PEPG) Stock at the Top of the Biotechnology Industry?

A rating of 76 puts PepGen Inc (PEPG) near the top of the Biotechnology industry according to InvestorsObserver. PepGen Inc's score of 76 means it scores higher than 76% of stocks in the industry. PepGen Inc also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 18 out of the 148 industries.

Overall Score - 64
PEPG has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on PEPG!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 64 would rank higher than 64 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With PepGen Inc Stock Today?

PepGen Inc (PEPG) stock is up 3.67% while the S&P 500 is lower by -0.14% as of 9:50 AM on Wednesday, Mar 13. PEPG is up $0.51 from the previous closing price of $13.89 on volume of 2,420 shares. Over the past year the S&P 500 has risen 31.87% while PEPG is up 2.86%. PEPG lost -$3.12 per share the over the last 12 months. Click Here to get the full Stock Report for PepGen Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App